Use of Anti-Cytokine Therapy in Kidney Transplant Recipients with COVID-19
In the context of the coronavirus disease 2019 (COVID-19) pandemic, we aimed to evaluate the impact of anti-cytokine therapies (AT) in kidney transplant recipients requiring hospitalization due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This is an observational retros...
Main Authors: | Marta Bodro, Frederic Cofan, Jose Ríos, Sabina Herrera, Laura Linares, María Angeles Marcos, Alex Soriano, Asunción Moreno, Fritz Diekmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/8/1551 |
Similar Items
-
BK Virus and Cytomegalovirus Coinfections in Kidney Transplantation and Their Impact on Allograft Loss
by: Sabina Herrera, et al.
Published: (2021-08-01) -
Perioperative prophylaxis with ertapenem reduced infections caused by extended-spectrum betalactamase-producting Enterobacteriaceae after kidney transplantation
by: Gemma Sanclemente, et al.
Published: (2019-07-01) -
Successful immunomodulation in kidney transplant recipients with cytokine release syndrome after coronavirus disease
by: Daiji Takamoto, et al.
Published: (2022-09-01) -
Vitamin D supplementation reduced blood inflammatory cytokines expression and improved graft function in kidney transplant recipients
by: Yang-Juan Bai, et al.
Published: (2023-07-01) -
Patterns of Circulating Cytokines and Vascular Markers’ Response in the Presence of COVID-19 in Kidney Transplant Recipients Compared with Non-Transplanted Patients
by: Milena Karina Coló Brunialti, et al.
Published: (2023-10-01)